临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2014年
8期
1005-1006
,共2页
丁新民%林树文%智明%万里鹏%吉成岗
丁新民%林樹文%智明%萬裏鵬%吉成崗
정신민%림수문%지명%만리붕%길성강
内镜下逆行胰胆管造影术%经皮肝穿刺胆道镜取石术%胆总管结石%肝胆管结石
內鏡下逆行胰膽管造影術%經皮肝穿刺膽道鏡取石術%膽總管結石%肝膽管結石
내경하역행이담관조영술%경피간천자담도경취석술%담총관결석%간담관결석
Endoscopic retrograde cholangiopancreatography (ERCP)%Percutaneous transhepatic cholangioscopy lithotripsy (PTCS)%Choledocholithiasis%Hepatolithiasis
目的:探讨经十二指肠镜逆行取石(ERCP)与经皮肝胆道镜顺行取石(PTCS)联合治疗胆总管结石合并肝胆管结石的疗效。方法对25例胆总管结石合并肝胆管结石患者行ERCP+PTCS治疗,即在ERCP治疗胆总管结石后即可行经皮肝穿刺胆道造瘘术,术后5~7天行经瘘道胆道镜取石术。总结临床资料,并与同期27例行胆总管切开胆道镜探查取石治疗的患者资料对比分析。结果ERCP与PTCS术联合治疗胆总管结石合并肝内胆管结石25例,结石取净率为96.0%,优于对照组的70.4%(P<0.05);并发症发生率相当,住院时间较短,花费相对较多(P<0.01)。结论ERCP联合PTCS是治疗胆总管结石合并肝胆管结石的安全有效的方法。
目的:探討經十二指腸鏡逆行取石(ERCP)與經皮肝膽道鏡順行取石(PTCS)聯閤治療膽總管結石閤併肝膽管結石的療效。方法對25例膽總管結石閤併肝膽管結石患者行ERCP+PTCS治療,即在ERCP治療膽總管結石後即可行經皮肝穿刺膽道造瘺術,術後5~7天行經瘺道膽道鏡取石術。總結臨床資料,併與同期27例行膽總管切開膽道鏡探查取石治療的患者資料對比分析。結果ERCP與PTCS術聯閤治療膽總管結石閤併肝內膽管結石25例,結石取淨率為96.0%,優于對照組的70.4%(P<0.05);併髮癥髮生率相噹,住院時間較短,花費相對較多(P<0.01)。結論ERCP聯閤PTCS是治療膽總管結石閤併肝膽管結石的安全有效的方法。
목적:탐토경십이지장경역행취석(ERCP)여경피간담도경순행취석(PTCS)연합치료담총관결석합병간담관결석적료효。방법대25례담총관결석합병간담관결석환자행ERCP+PTCS치료,즉재ERCP치료담총관결석후즉가행경피간천자담도조루술,술후5~7천행경루도담도경취석술。총결림상자료,병여동기27례행담총관절개담도경탐사취석치료적환자자료대비분석。결과ERCP여PTCS술연합치료담총관결석합병간내담관결석25례,결석취정솔위96.0%,우우대조조적70.4%(P<0.05);병발증발생솔상당,주원시간교단,화비상대교다(P<0.01)。결론ERCP연합PTCS시치료담총관결석합병간담관결석적안전유효적방법。
Objective To discuss the effect of encoscopic retrograde cholangio-pancreatogra (ERCP) and percutaneous transhepatic cholangioscopy (PTCS) in the treatment of choledocholithiasis complicated with hepatolithiasis. Methods 25 patients with choledocholithiasis and hepatolithiasis were treated with ERCP+PTCS (patients received percutaneous transhepatic gastrostomy after ERCP treatment of common bile duct stones, and were treat with fistula choledochofiberscopy 5~7 days after the first surgical operation). The clinical data were compared with 27 patients treated with choledochotomy choledochoscopic lithotomy. Results Among 25 cases of choledocholithiasis and hepatolithiasis treated with ERCP+PTCS, the stone clearance rate was 96.0%, better than 70.4%of control group (P<0.05), with similar complication rate, shorter length of hospital stay and relatively high costs (P >0.05). Conclusions The combination therapy of ERCP and PTCS is a safe and effective way to treat choledocholithiasis and hepatolithiasis.